Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Raw Materials (2020 - 2024)

Historic Raw Materials for IceCure Medical (ICCM) over the last 5 years, with Q4 2024 value amounting to $1.4 million.

  • IceCure Medical's Raw Materials rose 122.21% to $1.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.4 million, marking a year-over-year increase of 122.21%. This contributed to the annual value of $1.4 million for FY2024, which is 122.21% up from last year.
  • IceCure Medical's Raw Materials amounted to $1.4 million in Q4 2024, which was up 122.21% from $1.4 million recorded in Q4 2023.
  • Over the past 5 years, IceCure Medical's Raw Materials peaked at $1.6 million during Q4 2022, and registered a low of $380000.0 during Q4 2020.
  • Over the past 5 years, IceCure Medical's median Raw Materials value was $1.4 million (recorded in 2023), while the average stood at $1.1 million.
  • In the last 5 years, IceCure Medical's Raw Materials soared by 12244.32% in 2022 and then plummeted by 1117.5% in 2023.
  • Quarter analysis of 5 years shows IceCure Medical's Raw Materials stood at $380000.0 in 2020, then skyrocketed by 85.26% to $704000.0 in 2021, then soared by 122.44% to $1.6 million in 2022, then decreased by 11.17% to $1.4 million in 2023, then increased by 1.22% to $1.4 million in 2024.
  • Its Raw Materials was $1.4 million in Q4 2024, compared to $1.4 million in Q4 2023 and $1.6 million in Q4 2022.